Wu Liangliang, Dong Gaiying, Wu Tingting, Gu Xiaofan, Zhang Yuping, Wang Shunqing
Department of Hematology, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, People's Republic of China.
Department of Medical Ultrasound, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, People's Republic of China.
Hematology. 2025 Dec;30(1):2542634. doi: 10.1080/16078454.2025.2542634. Epub 2025 Aug 6.
Limited evidence exists on the association between the endothelial activation and stress index (EASIX) and mortality in anemia patients. This national cross-sectional study investigated the relationship between the EASIX and all-cause mortality in anemic individuals and assessed its clinical utility.
We analyzed data from 2954 anemia patients in the NHANES (2003-2016), with mortality follow-up through December 31, 2019. Restricted cubic spline (RCS) analysis evaluated the EASIX-mortality association. The optimal EASIX cutoff value for survival was determined using the maximally selected rank statistics method (MSRSM). Weighted multivariate Cox regression and time-dependent receiver operating characteristic (ROC) curve analysis assessed EASIX's predictive performance.
Over a median 81-month follow-up, 840 deaths (28.4%) occurred. RCS regression analysis revealed that higher EASIX scores were associated with increased all-cause mortality. Patients were categorized into lower (≤0.72) and higher (>0.72) EASIX groups based on the MSRM results. According to the multivariate-adjusted model, compared with the lower EASIX group, the higher EASIX group demonstrated an HR of 1.42 for all-cause mortality. Time-dependent ROC analysis revealed AUCs of 0.75, 0.75, 0.76, and 0.78 for 1-, 3-, 5-, and 10-year all-cause mortality, respectively.
An elevated EASIX score, derived from routine clinical parameters, is independently associated with increased all-cause mortality in anemic patients. These findings suggest that the EASIX may serve as a valuable prognostic biomarker for risk stratification and could assist in guiding the management of anemia. Further prospective cohort studies are needed to confirm its prognostic value in this population.
关于内皮激活与应激指数(EASIX)和贫血患者死亡率之间的关联,现有证据有限。这项全国性横断面研究调查了EASIX与贫血个体全因死亡率之间的关系,并评估了其临床效用。
我们分析了美国国家健康与营养检查调查(NHANES,2003 - 2016年)中2954例贫血患者的数据,并对其进行了至2019年12月31日的死亡率随访。受限立方样条(RCS)分析评估了EASIX与死亡率之间的关联。使用最大选择秩统计方法(MSRSM)确定生存的最佳EASIX临界值。加权多变量Cox回归和时间依赖性受试者工作特征(ROC)曲线分析评估了EASIX的预测性能。
在中位81个月的随访期内,发生了840例死亡(28.4%)。RCS回归分析显示,较高的EASIX评分与全因死亡率增加相关。根据MSRM结果,将患者分为EASIX较低(≤0.72)和较高(>0.72)两组。根据多变量调整模型,与EASIX较低组相比,EASIX较高组的全因死亡率风险比(HR)为1.42。时间依赖性ROC分析显示,1年、3年、5年和10年全因死亡率的曲线下面积(AUC)分别为0.75、0.75、0.76和0.78。
从常规临床参数得出的升高的EASIX评分与贫血患者全因死亡率增加独立相关。这些发现表明,EASIX可能作为一种有价值的预后生物标志物用于风险分层,并有助于指导贫血的管理。需要进一步的前瞻性队列研究来证实其在该人群中的预后价值。